Key result
Patients with overlap syndrome (coexisting COPD and OSA) had a higher prevalence of multiple (≥4) comorbidities compared to patients with OSA alone (28.95% vs. 10.52%).
Why the study?
Does overlap syndrome (COPD and OSA) increase the prevalence of cardiovascular and other comorbidities compared to OSA alone?
Cross-Sectional (n=76)
Does overlap syndrome (COPD and OSA) increase the prevalence of cardiovascular and other comorbidities compared to OSA alone?
Absolute Event Rate: 28.95% vs 10.52%
Patients with overlap syndrome (COPD and OSA) have a higher burden of multiple comorbidities, particularly cardiovascular disease, compared to patients with OSA alone.
Overlap syndrome may warrant closer comorbidity monitoring than OSA alone; leaves open whether this alters management pending prospective data.
No takes yet. Share an insight, caveat, or question.
Papachatzakis et al. (2018) conducted a cross-sectional in COPD and OSA (overlap syndrome) (n=76). Overlap syndrome (coexisting COPD and OSA) vs. OSA only was evaluated on Multiple (≥ 4) comorbidities. Patients with overlap syndrome (coexisting COPD and OSA) had a higher prevalence of multiple (≥4) comorbidities compared to patients with OSA alone (28.95% vs. 10.52%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: